School of Medicine
Showing 2,341-2,350 of 2,404 Results
-
Alan Yeung, MD
Li Ka Shing Professor in Cardiology
Current Research and Scholarly InterestsCoronary artery disease is the leading cause of death in men and women in the United States. Our group is interested in studying both the early and late phases of atherosclerosis so that we can better develop prevention and treatment strategies.
-
Celina Yong, MD, MBA, MSc
Associate Professor of Medicine (Cardiovascular Medicine)
BioCelina Yong, MD, MBA, MSc, FACC, FAHA, FSCAI, is an Associate Professor in the Stanford School of Medicine and Director of Interventional Cardiology at the VA Palo Alto Medical Center. Dr. Yong leads an active health services research lab focused on using large database analyses and novel scalable approaches to improve the quality of cardiovascular care. In her clinical practice, Dr. Yong performs complex percutaneous coronary interventions and transcatheter aortic valve replacements. She is actively involved in clinical trials of novel device and drug therapies for cardiovascular disease. She serves as an Associate Editor for the Journal of the American College of Cardiology and leads the VA-Cardiovascular Trials Consortium.
Prior to joining the Stanford faculty, Dr. Yong completed an MSc in Health Policy, Planning and Financing from the London School of Economics and MBA from Oxford as a Marshall Scholar. She completed her MD at Stanford, internal medicine residency at UCSF, and cardiology and interventional cardiology fellowships at Stanford. -
Shady Younis
Instructor, Medicine - Immunology & Rheumatology
BioShady Younis, PhD is an instructor at the division of Immunology and Rheumatology at Stanford University. He received his PhD in Medical Sciences from Uppsala University in Sweden. He later joined Dr. William Robinson’s Lab at Stanford University as Wallenberg postdoctoral fellow, where he characterized the pathogenic role of cytotoxic CD8+ T cells in rheumatoid arthritis. His current research aimed at elucidating the underlying triggers of pathogenic B cell responses in a spectrum of autoimmune diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and multiple sclerosis (MS). He uses computational methodologies alongside cutting-edge high-throughput sequencing technologies to characterize the autoreactive B and T cells. The overarching research objective of his research is to unravel the mechanistic roles of Epstein-Barr Virus (EBV) reactivation in activating and transforming autoreactive B cells in the development of autoimmunity.
